Medical Care
Global Pruritus Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- Mar 27, 25
- ID: 162489
- Pages: 98
- Figures: 97
- Views: 42
The global Pruritus Therapeutics market size was US$ 14790 million in 2024 and is forecast to a readjusted size of US$ 19380 million by 2031 with a CAGR of 4.0% during the forecast period 2025-2031.
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
The global Pruritus Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
By Type: (Dominant Segment vs High-Margin Innovation)
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
External Use
Oral
Injection
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., J&J in Europe)
- Emerging Product Trends: Antihistamines adoption vs. Corticosteroids premiumization
- Demand-Side Dynamics: External Use growth in China vs. Oral potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pruritus Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Corticosteroids in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Oral in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pruritus Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
Pruritus is a sensation that causes the desire or reflex to scratch. Pruritus has resisted many attempts to classify it as any one type of sensory experience. Modern science has shown that Pruritus has many similarities to pain, and while both are unpleasant sensory experiences, their behavioral response patterns are different. Pain creates a withdrawal reflex, whereas Pruritus leads to a scratch reflex.
In this report, we study the drugs for pruritus.
Market competition is intense. J&J, Abbott, Amgen and LEO Pharma, etc. are the leaders of the industry, with about 60% market shares.
North America is the largest consumption place, with a revenue market share nearly 43%. Following North America, Europe is the second largest consumption place with the revenue market share of 27%.
The global Pruritus Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
J&J
Abbott
Amgen
LEO Pharma
Novartis
Bayer
Pfizer
UCB Pharma
GlaxoSmithKline
Galderma
Huapont
By Type: (Dominant Segment vs High-Margin Innovation)
Antihistamines
Corticosteroids
Calcineurin Inhibitors
Others
By Application: (Core Demand Driver vs Emerging Opportunity)
External Use
Oral
Injection
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., J&J in Europe)
- Emerging Product Trends: Antihistamines adoption vs. Corticosteroids premiumization
- Demand-Side Dynamics: External Use growth in China vs. Oral potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Pruritus Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Corticosteroids in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Oral in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Pruritus Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pruritus Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Pruritus Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Pruritus Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.3 China Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.4 Japan Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.6 India Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.7 Central & South America Pruritus Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Pruritus Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Pruritus Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Pruritus Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Pruritus Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pruritus Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pruritus Therapeutics Revenue
5.4 Global Pruritus Therapeutics Market Concentration Analysis
5.4.1 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pruritus Therapeutics Revenue in 2024
5.5 Global Key Players of Pruritus Therapeutics Head office and Area Served
5.6 Global Key Players of Pruritus Therapeutics, Product and Application
5.7 Global Key Players of Pruritus Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Pruritus Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pruritus Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Pruritus Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pruritus Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Pruritus Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Pruritus Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pruritus Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Pruritus Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pruritus Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Pruritus Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Pruritus Therapeutics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Pruritus Therapeutics Market Size by Type (2020-2025)
6.3.2.2 China Pruritus Therapeutics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Pruritus Therapeutics Market Size by Application (2020-2025)
6.3.3.2 China Pruritus Therapeutics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Pruritus Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Pruritus Therapeutics Market Size by Type (2020-2025)
6.4.2.2 Japan Pruritus Therapeutics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Pruritus Therapeutics Market Size by Application (2020-2025)
6.4.3.2 Japan Pruritus Therapeutics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Pruritus Therapeutics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Pruritus Therapeutics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Pruritus Therapeutics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Pruritus Therapeutics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Pruritus Therapeutics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Pruritus Therapeutics Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Pruritus Therapeutics Market Size by Type (2020-2025)
6.6.2.2 India Pruritus Therapeutics Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Pruritus Therapeutics Market Size by Application (2020-2025)
6.6.3.2 India Pruritus Therapeutics Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 J&J
7.1.1 J&J Company Details
7.1.2 J&J Business Overview
7.1.3 J&J Pruritus Therapeutics Introduction
7.1.4 J&J Revenue in Pruritus Therapeutics Business (2020-2025)
7.1.5 J&J Recent Development
7.2 Abbott
7.2.1 Abbott Company Details
7.2.2 Abbott Business Overview
7.2.3 Abbott Pruritus Therapeutics Introduction
7.2.4 Abbott Revenue in Pruritus Therapeutics Business (2020-2025)
7.2.5 Abbott Recent Development
7.3 Amgen
7.3.1 Amgen Company Details
7.3.2 Amgen Business Overview
7.3.3 Amgen Pruritus Therapeutics Introduction
7.3.4 Amgen Revenue in Pruritus Therapeutics Business (2020-2025)
7.3.5 Amgen Recent Development
7.4 LEO Pharma
7.4.1 LEO Pharma Company Details
7.4.2 LEO Pharma Business Overview
7.4.3 LEO Pharma Pruritus Therapeutics Introduction
7.4.4 LEO Pharma Revenue in Pruritus Therapeutics Business (2020-2025)
7.4.5 LEO Pharma Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Pruritus Therapeutics Introduction
7.5.4 Novartis Revenue in Pruritus Therapeutics Business (2020-2025)
7.5.5 Novartis Recent Development
7.6 Bayer
7.6.1 Bayer Company Details
7.6.2 Bayer Business Overview
7.6.3 Bayer Pruritus Therapeutics Introduction
7.6.4 Bayer Revenue in Pruritus Therapeutics Business (2020-2025)
7.6.5 Bayer Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Details
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Pruritus Therapeutics Introduction
7.7.4 Pfizer Revenue in Pruritus Therapeutics Business (2020-2025)
7.7.5 Pfizer Recent Development
7.8 UCB Pharma
7.8.1 UCB Pharma Company Details
7.8.2 UCB Pharma Business Overview
7.8.3 UCB Pharma Pruritus Therapeutics Introduction
7.8.4 UCB Pharma Revenue in Pruritus Therapeutics Business (2020-2025)
7.8.5 UCB Pharma Recent Development
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Details
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Pruritus Therapeutics Introduction
7.9.4 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2020-2025)
7.9.5 GlaxoSmithKline Recent Development
7.10 Galderma
7.10.1 Galderma Company Details
7.10.2 Galderma Business Overview
7.10.3 Galderma Pruritus Therapeutics Introduction
7.10.4 Galderma Revenue in Pruritus Therapeutics Business (2020-2025)
7.10.5 Galderma Recent Development
7.11 Huapont
7.11.1 Huapont Company Details
7.11.2 Huapont Business Overview
7.11.3 Huapont Pruritus Therapeutics Introduction
7.11.4 Huapont Revenue in Pruritus Therapeutics Business (2020-2025)
7.11.5 Huapont Recent Development
8 Pruritus Therapeutics Market Dynamics
8.1 Pruritus Therapeutics Industry Trends
8.2 Pruritus Therapeutics Market Drivers
8.3 Pruritus Therapeutics Market Challenges
8.4 Pruritus Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Antihistamines
1.2.3 Corticosteroids
1.2.4 Calcineurin Inhibitors
1.2.5 Others
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 External Use
1.3.3 Oral
1.3.4 Injection
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pruritus Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Pruritus Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Pruritus Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.3 China Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.4 Japan Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.5 Southeast Asia Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.6 India Pruritus Therapeutics Market Size and Prospective (2020-2031)
2.5.7 Central & South America Pruritus Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Pruritus Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Pruritus Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Pruritus Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Pruritus Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Pruritus Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Pruritus Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Pruritus Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Pruritus Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Pruritus Therapeutics Revenue
5.4 Global Pruritus Therapeutics Market Concentration Analysis
5.4.1 Global Pruritus Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Pruritus Therapeutics Revenue in 2024
5.5 Global Key Players of Pruritus Therapeutics Head office and Area Served
5.6 Global Key Players of Pruritus Therapeutics, Product and Application
5.7 Global Key Players of Pruritus Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Pruritus Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Pruritus Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Pruritus Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Pruritus Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Pruritus Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Pruritus Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Pruritus Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Pruritus Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Pruritus Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Pruritus Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Pruritus Therapeutics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Pruritus Therapeutics Market Size by Type (2020-2025)
6.3.2.2 China Pruritus Therapeutics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Pruritus Therapeutics Market Size by Application (2020-2025)
6.3.3.2 China Pruritus Therapeutics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Pruritus Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Pruritus Therapeutics Market Size by Type (2020-2025)
6.4.2.2 Japan Pruritus Therapeutics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Pruritus Therapeutics Market Size by Application (2020-2025)
6.4.3.2 Japan Pruritus Therapeutics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 Southeast Asia Market: Players, Segments and Downstream
6.5.1 Southeast Asia Pruritus Therapeutics Revenue by Company (2020-2025)
6.5.2 Southeast Asia Market Size by Type
6.5.2.1 Southeast Asia Pruritus Therapeutics Market Size by Type (2020-2025)
6.5.2.2 Southeast Asia Pruritus Therapeutics Market Share by Type (2020-2025)
6.5.3 Southeast Asia Market Size by Application
6.5.3.1 Southeast Asia Pruritus Therapeutics Market Size by Application (2020-2025)
6.5.3.2 Southeast Asia Pruritus Therapeutics Market Share by Application (2020-2025)
6.5.4 Southeast Asia Market Trend and Opportunities
6.6 India Market: Players, Segments and Downstream
6.6.1 India Pruritus Therapeutics Revenue by Company (2020-2025)
6.6.2 India Market Size by Type
6.6.2.1 India Pruritus Therapeutics Market Size by Type (2020-2025)
6.6.2.2 India Pruritus Therapeutics Market Share by Type (2020-2025)
6.6.3 India Market Size by Application
6.6.3.1 India Pruritus Therapeutics Market Size by Application (2020-2025)
6.6.3.2 India Pruritus Therapeutics Market Share by Application (2020-2025)
6.6.4 India Market Trend and Opportunities
7 Key Players Profiles
7.1 J&J
7.1.1 J&J Company Details
7.1.2 J&J Business Overview
7.1.3 J&J Pruritus Therapeutics Introduction
7.1.4 J&J Revenue in Pruritus Therapeutics Business (2020-2025)
7.1.5 J&J Recent Development
7.2 Abbott
7.2.1 Abbott Company Details
7.2.2 Abbott Business Overview
7.2.3 Abbott Pruritus Therapeutics Introduction
7.2.4 Abbott Revenue in Pruritus Therapeutics Business (2020-2025)
7.2.5 Abbott Recent Development
7.3 Amgen
7.3.1 Amgen Company Details
7.3.2 Amgen Business Overview
7.3.3 Amgen Pruritus Therapeutics Introduction
7.3.4 Amgen Revenue in Pruritus Therapeutics Business (2020-2025)
7.3.5 Amgen Recent Development
7.4 LEO Pharma
7.4.1 LEO Pharma Company Details
7.4.2 LEO Pharma Business Overview
7.4.3 LEO Pharma Pruritus Therapeutics Introduction
7.4.4 LEO Pharma Revenue in Pruritus Therapeutics Business (2020-2025)
7.4.5 LEO Pharma Recent Development
7.5 Novartis
7.5.1 Novartis Company Details
7.5.2 Novartis Business Overview
7.5.3 Novartis Pruritus Therapeutics Introduction
7.5.4 Novartis Revenue in Pruritus Therapeutics Business (2020-2025)
7.5.5 Novartis Recent Development
7.6 Bayer
7.6.1 Bayer Company Details
7.6.2 Bayer Business Overview
7.6.3 Bayer Pruritus Therapeutics Introduction
7.6.4 Bayer Revenue in Pruritus Therapeutics Business (2020-2025)
7.6.5 Bayer Recent Development
7.7 Pfizer
7.7.1 Pfizer Company Details
7.7.2 Pfizer Business Overview
7.7.3 Pfizer Pruritus Therapeutics Introduction
7.7.4 Pfizer Revenue in Pruritus Therapeutics Business (2020-2025)
7.7.5 Pfizer Recent Development
7.8 UCB Pharma
7.8.1 UCB Pharma Company Details
7.8.2 UCB Pharma Business Overview
7.8.3 UCB Pharma Pruritus Therapeutics Introduction
7.8.4 UCB Pharma Revenue in Pruritus Therapeutics Business (2020-2025)
7.8.5 UCB Pharma Recent Development
7.9 GlaxoSmithKline
7.9.1 GlaxoSmithKline Company Details
7.9.2 GlaxoSmithKline Business Overview
7.9.3 GlaxoSmithKline Pruritus Therapeutics Introduction
7.9.4 GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2020-2025)
7.9.5 GlaxoSmithKline Recent Development
7.10 Galderma
7.10.1 Galderma Company Details
7.10.2 Galderma Business Overview
7.10.3 Galderma Pruritus Therapeutics Introduction
7.10.4 Galderma Revenue in Pruritus Therapeutics Business (2020-2025)
7.10.5 Galderma Recent Development
7.11 Huapont
7.11.1 Huapont Company Details
7.11.2 Huapont Business Overview
7.11.3 Huapont Pruritus Therapeutics Introduction
7.11.4 Huapont Revenue in Pruritus Therapeutics Business (2020-2025)
7.11.5 Huapont Recent Development
8 Pruritus Therapeutics Market Dynamics
8.1 Pruritus Therapeutics Industry Trends
8.2 Pruritus Therapeutics Market Drivers
8.3 Pruritus Therapeutics Market Challenges
8.4 Pruritus Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pruritus Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Pruritus Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pruritus Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Pruritus Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Pruritus Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Pruritus Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Pruritus Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Pruritus Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Pruritus Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Pruritus Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Pruritus Therapeutics Application
Table 18. Global Pruritus Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Pruritus Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Pruritus Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2024)
Table 21. Ranking of Global Top Pruritus Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Pruritus Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Pruritus Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Pruritus Therapeutics, Product and Application
Table 25. Global Key Players of Pruritus Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. China Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. Japan Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 49. India Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 51. J&J Company Details
Table 52. J&J Business Overview
Table 53. J&J Pruritus Therapeutics Product
Table 54. J&J Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 55. J&J Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott Pruritus Therapeutics Product
Table 59. Abbott Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Amgen Company Details
Table 62. Amgen Business Overview
Table 63. Amgen Pruritus Therapeutics Product
Table 64. Amgen Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. LEO Pharma Company Details
Table 67. LEO Pharma Business Overview
Table 68. LEO Pharma Pruritus Therapeutics Product
Table 69. LEO Pharma Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 70. LEO Pharma Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Pruritus Therapeutics Product
Table 74. Novartis Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Pruritus Therapeutics Product
Table 79. Bayer Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Pruritus Therapeutics Product
Table 84. Pfizer Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. UCB Pharma Company Details
Table 87. UCB Pharma Business Overview
Table 88. UCB Pharma Pruritus Therapeutics Product
Table 89. UCB Pharma Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 90. UCB Pharma Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Pruritus Therapeutics Product
Table 94. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Galderma Company Details
Table 97. Galderma Business Overview
Table 98. Galderma Pruritus Therapeutics Product
Table 99. Galderma Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Galderma Recent Development
Table 101. Huapont Company Details
Table 102. Huapont Business Overview
Table 103. Huapont Pruritus Therapeutics Product
Table 104. Huapont Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Huapont Recent Development
Table 106. Pruritus Therapeutics Market Trends
Table 107. Pruritus Therapeutics Market Drivers
Table 108. Pruritus Therapeutics Market Challenges
Table 109. Pruritus Therapeutics Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Pruritus Therapeutics Product Picture
Figure 2. Global Pruritus Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Antihistamines Features
Figure 4. Corticosteroids Features
Figure 5. Calcineurin Inhibitors Features
Figure 6. Others Features
Figure 7. Global Pruritus Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. External Use
Figure 9. Oral
Figure 10. Injection
Figure 11. Pruritus Therapeutics Report Years Considered
Figure 12. Global Pruritus Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Pruritus Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pruritus Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Southeast Asia Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Central & South America Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Pruritus Therapeutics Market Share by Players in 2024
Figure 23. Global Top Pruritus Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Pruritus Therapeutics Revenue in 2024
Figure 25. North America Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 26. North America Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 27. Europe Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 28. Europe Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 29. China Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 30. China Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 31. Japan Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 32. Japan Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 33. Southeast Asia Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 34. Southeast Asia Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 35. India Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 36. India Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 37. J&J Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 38. Abbott Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 39. Amgen Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 40. LEO Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 41. Novartis Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 42. Bayer Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 43. Pfizer Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 44. UCB Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 46. Galderma Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 47. Huapont Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Table 1. Global Pruritus Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pruritus Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Pruritus Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Pruritus Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Pruritus Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Pruritus Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Pruritus Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Pruritus Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Pruritus Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Pruritus Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Pruritus Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Pruritus Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Pruritus Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Pruritus Therapeutics Application
Table 18. Global Pruritus Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Pruritus Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Pruritus Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2024)
Table 21. Ranking of Global Top Pruritus Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Pruritus Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Pruritus Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Pruritus Therapeutics, Product and Application
Table 25. Global Key Players of Pruritus Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. China Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. Japan Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. Southeast Asia Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. Southeast Asia Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. Southeast Asia Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. Southeast Asia Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. India Pruritus Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 48. India Pruritus Therapeutics Revenue Market Share by Company (2020-2025)
Table 49. India Pruritus Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 50. India Pruritus Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 51. J&J Company Details
Table 52. J&J Business Overview
Table 53. J&J Pruritus Therapeutics Product
Table 54. J&J Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 55. J&J Recent Development
Table 56. Abbott Company Details
Table 57. Abbott Business Overview
Table 58. Abbott Pruritus Therapeutics Product
Table 59. Abbott Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 60. Abbott Recent Development
Table 61. Amgen Company Details
Table 62. Amgen Business Overview
Table 63. Amgen Pruritus Therapeutics Product
Table 64. Amgen Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 65. Amgen Recent Development
Table 66. LEO Pharma Company Details
Table 67. LEO Pharma Business Overview
Table 68. LEO Pharma Pruritus Therapeutics Product
Table 69. LEO Pharma Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 70. LEO Pharma Recent Development
Table 71. Novartis Company Details
Table 72. Novartis Business Overview
Table 73. Novartis Pruritus Therapeutics Product
Table 74. Novartis Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 75. Novartis Recent Development
Table 76. Bayer Company Details
Table 77. Bayer Business Overview
Table 78. Bayer Pruritus Therapeutics Product
Table 79. Bayer Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 80. Bayer Recent Development
Table 81. Pfizer Company Details
Table 82. Pfizer Business Overview
Table 83. Pfizer Pruritus Therapeutics Product
Table 84. Pfizer Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. UCB Pharma Company Details
Table 87. UCB Pharma Business Overview
Table 88. UCB Pharma Pruritus Therapeutics Product
Table 89. UCB Pharma Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 90. UCB Pharma Recent Development
Table 91. GlaxoSmithKline Company Details
Table 92. GlaxoSmithKline Business Overview
Table 93. GlaxoSmithKline Pruritus Therapeutics Product
Table 94. GlaxoSmithKline Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 95. GlaxoSmithKline Recent Development
Table 96. Galderma Company Details
Table 97. Galderma Business Overview
Table 98. Galderma Pruritus Therapeutics Product
Table 99. Galderma Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 100. Galderma Recent Development
Table 101. Huapont Company Details
Table 102. Huapont Business Overview
Table 103. Huapont Pruritus Therapeutics Product
Table 104. Huapont Revenue in Pruritus Therapeutics Business (2020-2025) & (US$ Million)
Table 105. Huapont Recent Development
Table 106. Pruritus Therapeutics Market Trends
Table 107. Pruritus Therapeutics Market Drivers
Table 108. Pruritus Therapeutics Market Challenges
Table 109. Pruritus Therapeutics Market Restraints
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Pruritus Therapeutics Product Picture
Figure 2. Global Pruritus Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Antihistamines Features
Figure 4. Corticosteroids Features
Figure 5. Calcineurin Inhibitors Features
Figure 6. Others Features
Figure 7. Global Pruritus Therapeutics Market Share by Application: 2024 VS 2031
Figure 8. External Use
Figure 9. Oral
Figure 10. Injection
Figure 11. Pruritus Therapeutics Report Years Considered
Figure 12. Global Pruritus Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Pruritus Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pruritus Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 15. North America Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Europe Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. China Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Japan Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 19. Southeast Asia Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 20. India Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 21. Central & South America Pruritus Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 22. Global Pruritus Therapeutics Market Share by Players in 2024
Figure 23. Global Top Pruritus Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pruritus Therapeutics as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Pruritus Therapeutics Revenue in 2024
Figure 25. North America Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 26. North America Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 27. Europe Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 28. Europe Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 29. China Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 30. China Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 31. Japan Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 32. Japan Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 33. Southeast Asia Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 34. Southeast Asia Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 35. India Pruritus Therapeutics Market Share by Type (2020-2025)
Figure 36. India Pruritus Therapeutics Market Share by Application (2020-2025)
Figure 37. J&J Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 38. Abbott Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 39. Amgen Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 40. LEO Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 41. Novartis Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 42. Bayer Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 43. Pfizer Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 44. UCB Pharma Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 45. GlaxoSmithKline Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 46. Galderma Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 47. Huapont Revenue Growth Rate in Pruritus Therapeutics Business (2020-2025)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232